SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Yasutsugu Takada, Taiji Tohyama, Jota Watanabe, Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation, Journal of Hepato-Biliary-Pancreatic Sciences, 2015, 22, 2
  2. 2
    Naoto Fujiwara, Ryosuke Tateishi, Hayato Nakagawa, Ryo Nakagomi, Mayuko Kondo, Tatsuya Minami, Masaya Sato, Koji Uchino, Kenichiro Enooku, Yuji Kondo, Yoshinari Asaoka, Shuichiro Shiina, Haruhiko Yoshida, Kazuhiko Koike, Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma, Hepatology Research, 2015, 45, 2
  3. 3
    Shozo Mori, Junji Kita, Masato Kato, Mitsugi Shimoda, Keiichi Kubota, Usefulness of a new inflammation-based scoring system for prognostication of patients with hepatocellular carcinoma after hepatectomy, The American Journal of Surgery, 2015, 209, 1, 187

    CrossRef

  4. 4
    Junichi Shindoh, Yasuhiko Sugawara, Rihito Nagata, Junichi Kaneko, Sumihito Tamura, Taku Aoki, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Tomohiro Tanaka, Norihiro Kokudo, Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma, Transplant International, 2014, 27, 4
  5. 5
    Quirino Lai, Jan P. Lerut, Hepatocellular cancer, Current Opinion in Organ Transplantation, 2014, 19, 3, 229

    CrossRef

  6. 6
    A. Kornberg, Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome, ISRN Hepatology, 2014, 2014, 1

    CrossRef

  7. 7
    Evangelos Cholongitas, Chrysanthi Mamou, Kryssia I. Rodríguez-Castro, Patrizia Burra, Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review, Transplant International, 2014, 27, 10
  8. 8
    Young-Kyu Kim, Seong Hoon Kim, Seung-Duk Lee, Soon-ae Lee, Sang-Jae Park, Pretransplant absolute monocyte count in peripheral blood predicts posttransplant tumor prognosis in patients undergoing liver transplantation for hepatocellular carcinoma, Hepatobiliary & Pancreatic Diseases International, 2014, 13, 3, 250

    CrossRef

  9. 9
    C.-C. Lin, C.-C. Chen, C.-L. Chen, T.-L. Huang, Association Between Serum C-Reactive Protein and Albumin Levels and Psychiatric Comorbidities in Liver Transplant Recipients, Transplantation Proceedings, 2013, 45, 6, 2337

    CrossRef

  10. 10
    Jean-François Dufour, C-reactive protein, a prognostic marker in hepatocellular carcinoma, Hepatology, 2013, 57, 6
  11. 11
    Angelo H. Paredes, Rohit Satoskar, Hepatocellular Carcinoma: When to Transplant Outside of Milan Criteria, Current Hepatitis Reports, 2013, 12, 1, 37

    CrossRef

  12. 12
    Chin-Chuen Lin, Chia-Ming Chang, Chia-Yih Liu, Tiao-Lai Huang, Increased high-sensitivity C-reactive protein levels in Taiwanese schizophrenic patients, Asia-Pacific Psychiatry, 2013, 5, 2